BNP Paribas Financial Markets
RUBY

BNP Paribas Financial Markets’s Rubius Therapeutics, Inc RUBY Stock Holding History

BNP Paribas Financial Markets’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,108
Closed -$1.07K – 4129
2022
Q4 		$1.07K Buy
6,108
+4,294
+237% +$1.17K ﹤0.01% 3796
2022
Q3 		$787 Sell
1,814
-3,082
-63% -$2.31K ﹤0.01% 4466
2022
Q2 		$4.17K Sell
4,896
-50,889
-91% -$85.4K ﹤0.01% 3839
2022
Q1 		$307K Buy
55,785
+38,998
+232% +$248K ﹤0.01% 2973
2021
Q4 		$162K Buy
16,787
+8,289
+98% +$115K ﹤0.01% 3449
2021
Q3 		$152K Buy
8,498
+6,678
+367% +$145K ﹤0.01% 3143
2021
Q2 		$44.4K Sell
1,820
-11,421
-86% -$286K ﹤0.01% 3299
2021
Q1 		$351K Buy
13,241
+4,609
+53% +$67.3K ﹤0.01% 2769
2020
Q4 		$65.5K Sell
8,632
-1,014
-11% -$6.02K ﹤0.01% 3429
2020
Q3 		$48.3K Buy
9,646
+7,047
+271% +$37.3K ﹤0.01% 3481
2020
Q2 		$15.5K Sell
2,599
-8,924
-77% -$52.7K ﹤0.01% 3504
2020
Q1 		$51.3K Buy
11,523
+6,727
+140% +$50K ﹤0.01% 3527
2019
Q4 		$45.6K Sell
4,796
-1,434
-23% -$13.9K ﹤0.01% 3699
2019
Q3 		$48.9K Buy
6,230
+1,666
+37% +$19.4K ﹤0.01% 3483
2019
Q2 		$71.8K Sell
4,564
-2,921
-39% -$47.1K ﹤0.01% 3221
2019
Q1 		$135K Buy
7,485
+7,446
+19,092% +$114K ﹤0.01% 2943
2018
Q4 		$627 Sell
39
-13
-25% -$237 ﹤0.01% 3981
2018
Q3 		$1.25K Buy
+52
New +$1.19K ﹤0.01% 4304

Other funds holding RUBY

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

BNP Paribas Financial Markets's RUBY Position: Q1 2023 in Review

BNP Paribas Financial Markets sold out of Rubius Therapeutics, Inc (RUBY) in Q1 2023, closing a stake of 6,108 shares — an estimated $1.07K sold.

BNP Paribas Financial Markets first reported a position in RUBY in Q3 2018 and held it in 18 quarters. The position peaked at $351K in Q1 2021. 7 funds tracked by Wall St. Rank hold RUBY as of Q1 2023.

  • BNP Paribas Financial Markets reported no remaining Rubius Therapeutics, Inc position as of Q1 2023 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 6,108 Rubius Therapeutics, Inc shares in Q1 2023, an estimated $1.07K.
  • BNP Paribas Financial Markets first reported a position in Rubius Therapeutics, Inc in Q3 2018 and held it in 18 quarters.
  • BNP Paribas Financial Markets's Rubius Therapeutics, Inc position peaked at $351K in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q1 2023.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2023, filed 12 May 2023.